Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Argus Pharmaceuticals Inc., Genzyme preclinical data

ARGS (The Woodlands, Texas) announced that its liposomal intravenous formulation potentially overcomes rapid removal of

Read the full 156 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE